JEFFS ROGER

CIK 00012316157 companiesMORRISVILLE, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001231615

Recent Transactions

50 trades

Award
Liquidia Corp$LQDA
Performance Stock Units
2026-01-16+173,016→ 173,016 total
Award
Liquidia Corp$LQDA
Common Stock
2026-01-16+115,344→ 1,152,872 total
Sale
Liquidia Corp$LQDA
Common Stock
2026-01-12$37.43/sh−66,610→ 1,037,528 total
Exercise/Conversion
Liquidia Corp$LQDA
Performance Stock Units
2026-01-09−13,833→ 110,669 total
Exercise/Conversion
Liquidia Corp$LQDA
Common Stock
2026-01-09+13,833→ 1,046,806 total
Exercise/Conversion
Liquidia Corp$LQDA
Performance Stock Units
2026-01-09−57,332→ 171,995 total
Exercise/Conversion
Liquidia Corp$LQDA
Common Stock
2026-01-09+57,332→ 1,104,138 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-10-13$23.41/sh−20,261→ 1,032,973 total
Exercise/Conversion
Liquidia Corp$LQDA
Performance Stock Units
2025-10-10−13,834→ 124,502 total
Exercise/Conversion
Liquidia Corp$LQDA
Common Stock
2025-10-10+13,834→ 1,053,234 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-09-02$123.68/sh−13,464→ 57,510 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-08-29$121.27/sh−20,000→ 70,974 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-08-28$121.60/sh−20,000→ 90,974 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-08-27$122.30/sh−20,000→ 110,974 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-08-26$120.03/sh−20,000→ 130,974 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2025-08-22$120.08/sh−16,694→ 150,974 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-07-14$14.28/sh−20,252→ 1,038,560 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-07-14$14.28/sh−20,252→ 1,038,560 total
Exercise/Conversion
Liquidia Corp$LQDA
Performance Stock Units
2025-07-11−13,833→ 138,336 total
Exercise/Conversion
Liquidia Corp$LQDA
Common Stock
2025-07-11+13,833→ 1,058,812 total
Exercise/Conversion
Liquidia Corp$LQDA
Performance Stock Units
2025-07-11−13,833→ 138,336 total
Exercise/Conversion
Liquidia Corp$LQDA
Common Stock
2025-07-11+13,833→ 1,058,812 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2025-06-06+1,429→ 1,429 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-06-06+3,166→ 3,166 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-06-04$16.97/sh−30,610→ 1,044,979 total
Exercise/Conversion
Liquidia Corp$LQDA
Performance Stock Units
2025-06-03−69,169→ 152,169 total
Exercise/Conversion
Liquidia Corp$LQDA
Common Stock
2025-06-03+69,169→ 1,075,589 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-04-14$13.57/sh−14,130→ 1,006,420 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2025-02-21+1,408→ 1,408 total
Sale
Liquidia Corp$LQDA
Common Stock
2025-01-14$11.78/sh−22,343→ 1,019,177 total
Award
Liquidia Corp$LQDA
Performance Stock Units
2025-01-11+229,327→ 229,327 total
Award
Liquidia Corp$LQDA
Common Stock
2025-01-11+229,327→ 1,041,520 total
Sale
Liquidia Corp$LQDA
Common Stock
2024-10-14$11.11/sh−8,053→ 812,193 total
Sale
Liquidia Corp$LQDA
Common Stock
2024-07-12$12.53/sh−8,053→ 818,932 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-06-07+5,799→ 5,799 total
Sale
Liquidia Corp$LQDA
Common Stock
2024-04-12$14.58/sh−8,360→ 826,985 total
Sale
Liquidia Corp$LQDA
Common Stock
2024-03-18$15.82/sh−28,583→ 835,345 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-03-15−2,347→ 0 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-03-15$29.91/sh+2,347→ 123,103 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-03-15$71.61/sh−2,347→ 120,756 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-03-14−13,000→ 0 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-03-14$69.70/sh−16,976→ 120,756 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-03-14$22.03/sh+13,000→ 133,756 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-03-14$25.53/sh+16,976→ 137,732 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2024-03-14$69.70/sh−13,000→ 120,756 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-03-14−16,976→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2024-02-27+1,425→ 1,425 total
Award
Liquidia Corp$LQDA
Common Stock
2024-01-11+221,338→ 862,143 total
Award
Liquidia Corp$LQDA
Performance Stock Units
2024-01-11+221,338→ 221,338 total
Purchase
Liquidia Corp$LQDA
Common Stock
2023-12-14$7.16/sh+139,665→ 640,805 total

Companies

Recent Filings

Address

419 DAVIS DRIVE, SUITE 100

MORRISVILLE, NC, 27560

View on SEC.gov